机器人经自然腔道取标本手术与机器人经腹取标本手术治疗早期直肠癌的多中心倾向性评分匹配分析
这项中国多中心回顾性队列研究纳入1086例接受机器人全直肠系膜切除术的早期直肠癌患者,经1:1倾向性评分匹配后形成318对。结果显示R-NOSES组手术时间更长,但术后排气、口服摄入和住院时间更短,伤口并发症更少,疼痛评分和额外镇痛需求更低,身体形象和功能评分更优,总体并发症率相似。
要点
- R-NOSES组手术时间显著长于R-TSES组,但术后恢复更快、住院时间更短。
- 两组总体并发症率相似,但R-NOSES组伤口并发症发生率显著更低。
- R-NOSES组术后疼痛更轻、额外镇痛更少,身体形象和功能评分更优。
核心结论
- 由熟练外科医生精细实施时,R-NOSES是早期直肠癌安全有效的治疗方式。
研究设计与样本
- 多中心回顾性队列研究,纳入2015年10月至2023年11月8个中国高容量结直肠癌中心接受R-NOSES或R-TSES的1086例患者。
- 纳入标准为组织学确诊直肠腺癌、机器人全直肠系膜切除、术后病理分期TisN0M0或T1-2N0M0、具备完整手术和术后随访数据。
- 采用倾向性评分匹配(PSM)技术按1:1匹配R-NOSES组和R-TSES组,匹配后形成318对。
主要发现
- R-NOSES组手术时间显著长于R-TSES组[140 min(125-170 min)vs. 140 min(120-160 min),P=0.032]。
- R-NOSES组首次排气时间和首次口服摄入时间显著短于R-TSES组[48 h(41-56 h)vs. 48 h(44-62 h),P=0.049;77 h(72-94 h)vs. 82 h(72-96 h),P=0.008]。
- R-NOSES组术后住院时间短于R-TSES组[7天(7-9天)vs. 8天(7-9天),P=0.005]。
- 两组总体术后并发症率相似(R-NOSES组10.7% vs. R-TSES组11.9%,P=0.617),但R-NOSES组伤口并发症发生率更低(0.0% vs. 2.2%,P=0.015)。
- R-NOSES组术后第1、3、5天额外镇痛需求更少、疼痛评分更低,身体形象量表(BIS)和美容量表(CS)评分显著更高,功能维度(躯体、角色、情绪、社会、认知)及疲劳、疼痛症状结局更优。
临床怎么用
- 对于早期直肠癌,在熟练外科医生操作下可考虑R-NOSES以加速术后恢复、减少伤口并发症并改善患者身体形象和功能结局。
- R-NOSES手术时间较长,需在术前规划和手术室安排中予以考虑。
- 实施R-NOSES需通过统一培训方案确保安全性和标准化。
局限性
- 研究为回顾性设计,可能存在选择偏倚。
- 需建立统一培训方案以确保R-NOSES安全规范实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite the global increase in the adoption of robotic natural orifice specimen extraction surgery (R-NOSES), its advantages over robotic transabdominal specimen extraction surgery (R-TSES) for treating early-stage rectal cancer remain debated. There is scant nationwide, multicenter studies comparing the surgical quality and short-term outcomes between R-NOSES and R-TSES for this condition. OBJECTIVE: This retrospective cohort study was conducted nationally across multiple centers to compare the surgical quality and short-term outcomes between R-NOSES and R-TSES in early-stage rectal cancer. DESIGN: Multicenter retrospective cohort trial. SETTING: Eight experienced surgeons from 8 high-volume Chinese colorectal cancer treatment centers. PATIENTS: The study included 1086 patients who underwent R-NOSES or R-TSES from October 2015 to November 2023 at the 8 centers. Inclusion criteria were: (1) histologically confirmed rectal adenocarcinoma; (2) robotic total mesorectal excision; (3) postoperative pathological staging of TisN0M0 or T1-2N0M0; (4) availability of complete surgical and postoperative follow-up data. Patients were matched 1:1 in the R-NOSES and R-TSES groups using the propensity score matching (PSM) technique. RESULTS: After PSM, 318 matched pairs with well-balanced patient characteristics were identified. The operation time for the R-NOSES group was significantly longer than that for the R-TSES group [140 min (125-170 min) vs. 140 min (120-160 min), P = 0.032]. Conversely, the times to first flatus and initial oral intake in the R-NOSES group were significantly shorter than those in the R-TSES group [48 h (41-56 h) vs. 48 h (44-62 h), P = 0.049 and 77 h (72-94 h) vs. 82 h (72-96 h), P = 0.008], respectively. Additionally, the length of postoperative hospital stay was shorter in the R-NOSES group compared with the R-TSES group [7 day (7-9 day) vs. 8 day (7-9 day), P = 0.005]. The overall postoperative complication rates were similar between the groups (10.7% in the R-NOSES group vs. 11.9% in the R-TSES group, P = 0.617). However, the R-NOSES group had a lower incidence of wound complications compared to the R-TSES group (0.0% vs. 2.2%, P = 0.015). Regarding surgical stress response, the R-NOSES group showed superior outcomes. Additionally, patients in the R-NOSES group required fewer additional analgesics on postoperative days 1, 3, and 5 and reported lower pain scores compared to the R-TSES group. The body image scale (BIS) and cosmetic scale (CS) scores were also significantly higher in the R-NOSES group. Furthermore, the R-NOSES group demonstrated significantly better outcomes in functional dimensions such as physical, role, emotional, social, and cognitive functioning, and in symptoms like fatigue and pain, when compared to the R-TSES group. LIMITATIONS: It is imperative to ensure the safe and standardized implementation of R-NOSES through the establishment of a uniform training protocol. CONCLUSIONS: These results affirm that R-NOSES is a safe and effective treatment for early-stage rectal cancer when meticulously executed by skilled surgeons.
引用
- Liu D, He G, Yao H, et al. Robotic natural orifice specimen extraction surgery versus robotic transabdominal specimen extraction surgery for early-stage rectal cancer: a multicenter propensity score-matched analysis (in China). Surg Endosc. 2024. PMID: 38914889. doi:10.1007/s00464-024-10995-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。